Organization
Rotterdam
6 abstracts
Abstract
Patient-reported outcomes (PROs) in primary advanced or recurrent endometrial cancer (pA/rEC) for patients (pts) treated with dostarlimab plus carboplatin/paclitaxel (CP) as compared to CP in the ENGOT-EN6/GOG3031/RUBY trial.Org: Copenhagen University Hospital, Washington University School of Medicine, ModernaTX, Rigshospitalet, Nordic Society of Gynaecologic Oncology–Clinical Trial Unit,
Abstract
Updated results of the INTELLANCE 2/EORTC trial 1410 randomized phase II study on Depatux –M alone, Depatux-M in combination with temozolomide (TMZ) and either TMZ or lomustine (LOM) in recurrent EGFR amplified glioblastoma (NCT02343406).Org: Erasmus MC Cancer Center, Rotterdam, Netherlands Cancer Institute, Erasmus MC Cancer Institute, University Medical Center, Department of Hematology, Rotterdam, Netherlands, Fondazione IRCCS Istituto Neurologico Carlo Besta,
Abstract
Innovative platforms for development of TCR-T cell therapies against novel tumor targets: Triple negative breast cancer.Org: Pan Cancer T, Rotterdam, Erasmus MC Cancer Institute, University Medical Center, Department of Hematology, Rotterdam, Netherlands,
Abstract
ANTI-TNF-ALPHA INHIBITS THE ANTIBODY RESPONSE TO INFLUENZA VACCINATIONOrg: Rheumatology, Society of Patients with Rheumatism, Cracow, Poland, Infectious Diseases Physicians, gastro-enterology, Leiden University Medical Center, Leiden University,
Abstract
ASSOCIATION BETWEEN VARUS-ALIGNMENT AND THE ONSET AND PROGRESSION OF OSTEOARTHRITIS OF THE KNEEOrg: General practice and Orhopaedics, University Medical Center, Rotterdam, Internal Medicine, Thomas Jefferson University, Philadelphia, United States, Orthopedics Research Institute of Zhejiang University, Erasmus MC Cancer Institute, University Medical Center, Department of Hematology, Rotterdam, Netherlands, Rotterdam,
Abstract
ACETABULAR DYSPLASIA PREDICTS OSTEOARTHRITIS OF THE HIP. THE ROTTERDAM STUDYOrg: General Practice Dept, Paris Diderot Univ, Paris, Rheumatology, Internal Medicine Residency, Erasmus MC Cancer Institute, University Medical Center, Department of Hematology, Rotterdam, Netherlands, Rotterdam,